169 related articles for article (PubMed ID: 20431511)
1. Mechanisms of differential expression of the CYP2A13 7520C and 7520G alleles in human lung: allelic expression analysis for CYP2A13 heterogeneous nuclear RNA, and evidence for the involvement of multiple cis-regulatory single nucleotide polymorphisms.
Wu H; Zhang X; Ling G; D'Agostino J; Ding X
Pharmacogenet Genomics; 2009 Nov; 19(11):852-63. PubMed ID: 20431511
[TBL] [Abstract][Full Text] [Related]
2. Development of a real-time polymerase chain reaction-based method for the measurement of relative allelic expression and identification of CYP2A13 alleles with decreased expression in human lung.
Zhang X; Caggana M; Cutler TL; Ding X
J Pharmacol Exp Ther; 2004 Oct; 311(1):373-81. PubMed ID: 15175424
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary expression of CYP2A13 and ABCB1 is regulated by FOXA2, and their genetic interaction is associated with lung cancer.
Xiang C; Wang J; Kou X; Chen X; Qin Z; Jiang Y; Sun C; Xu J; Tan W; Jin L; Lin D; He F; Wang H
FASEB J; 2015 May; 29(5):1986-98. PubMed ID: 25667220
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation of human CYP2A13 expression in the respiratory tract by CCAAT/enhancer binding protein and epigenetic modulation.
Ling G; Wei Y; Ding X
Mol Pharmacol; 2007 Mar; 71(3):807-16. PubMed ID: 17148654
[TBL] [Abstract][Full Text] [Related]
5. The missense genetic polymorphisms of human CYP2A13: functional significance in carcinogen activation and identification of a null allelic variant.
Wang SL; He XY; Shen J; Wang JS; Hong JY
Toxicol Sci; 2006 Nov; 94(1):38-45. PubMed ID: 16917071
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional suppression of CYP2A13 expression by lipopolysaccharide in cultured human lung cells and the lungs of a CYP2A13-humanized mouse model.
Wu H; Liu Z; Ling G; Lawrence D; Ding X
Toxicol Sci; 2013 Oct; 135(2):476-85. PubMed ID: 23884085
[TBL] [Abstract][Full Text] [Related]
7. Novel single nucleotide polymorphism of the CYP2A13 gene in Japanese individuals.
Tamaki Y; Honda M; Muroi Y; Arai T; Sugimura H; Matsubara Y; Kanno S; Ishikawa M; Hirasawa N; Hiratsuka M
Drug Metab Pharmacokinet; 2011; 26(5):544-7. PubMed ID: 21606606
[TBL] [Abstract][Full Text] [Related]
8. Characterization of CYP2A13*2, a variant cytochrome P450 allele previously found to be associated with decreased incidences of lung adenocarcinoma in smokers.
D'Agostino J; Zhang X; Wu H; Ling G; Wang S; Zhang QY; Liu F; Ding X
Drug Metab Dispos; 2008 Nov; 36(11):2316-23. PubMed ID: 18669584
[TBL] [Abstract][Full Text] [Related]
9. A nicotine C-oxidase gene (CYP2A6) polymorphism important for promoter activity.
Pitarque M; von Richter O; Rodríguez-Antona C; Wang J; Oscarson M; Ingelman-Sundberg M
Hum Mutat; 2004 Mar; 23(3):258-66. PubMed ID: 14974084
[TBL] [Abstract][Full Text] [Related]
10. Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
Su T; Bao Z; Zhang QY; Smith TJ; Hong JY; Ding X
Cancer Res; 2000 Sep; 60(18):5074-9. PubMed ID: 11016631
[TBL] [Abstract][Full Text] [Related]
11. Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK.
Wang H; Tan W; Hao B; Miao X; Zhou G; He F; Lin D
Cancer Res; 2003 Nov; 63(22):8057-61. PubMed ID: 14633739
[TBL] [Abstract][Full Text] [Related]
12. Regulatory single nucleotide polymorphisms (rSNPs) at the promoters 1A and 1B of the human APC gene.
Matveeva MY; Kashina EV; Reshetnikov VV; Bryzgalov LO; Antontseva EV; Bondar NP; Merkulova TI
BMC Genet; 2016 Dec; 17(Suppl 3):154. PubMed ID: 28105931
[TBL] [Abstract][Full Text] [Related]
13. Single nucleotide polymorphisms of the human cyp2a13 gene: evidence for a null allele.
Zhang X; Chen Y; Liu Y; Ren X; Zhang QY; Caggana M; Ding X
Drug Metab Dispos; 2003 Sep; 31(9):1081-5. PubMed ID: 12920161
[TBL] [Abstract][Full Text] [Related]
14. Dual effect of a single nucleotide polymorphism in the first intron of the porcine secreted phosphoprotein 1 gene: allele-specific binding of C/EBP beta and activation of aberrant splicing.
Muráni E; Ponsuksili S; Seyfert HM; Shi X; Wimmers K
BMC Mol Biol; 2009 Oct; 10():96. PubMed ID: 19845957
[TBL] [Abstract][Full Text] [Related]
15. CYP2A13: variable expression and role in human lung microsomal metabolic activation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
Zhang X; D'Agostino J; Wu H; Zhang QY; von Weymarn L; Murphy SE; Ding X
J Pharmacol Exp Ther; 2007 Nov; 323(2):570-8. PubMed ID: 17671098
[TBL] [Abstract][Full Text] [Related]
16. An investigation of the catalytic activity of CYP2A13*4 with coumarin and polymorphisms of CYP2A13 in a Chinese Han population.
Liu T; Hong Y; Li Z; Hong J; Zeng S; Zheng M; Chen S
Drug Metab Dispos; 2012 May; 40(5):847-51. PubMed ID: 22315333
[TBL] [Abstract][Full Text] [Related]
17. Expression of SMARCB1 modulates steroid sensitivity in human lymphoblastoid cells: identification of a promoter SNP that alters PARP1 binding and SMARCB1 expression.
Pottier N; Cheok MH; Yang W; Assem M; Tracey L; Obenauer JC; Panetta JC; Relling MV; Evans WE
Hum Mol Genet; 2007 Oct; 16(19):2261-71. PubMed ID: 17616514
[TBL] [Abstract][Full Text] [Related]
18. Association of FOXP3 and GAGE10 promoter polymorphisms and decreased FOXP3 expression in regulatory T cells with susceptibility to generalized vitiligo in Gujarat population.
Giri PS; Patel S; Begum R; Dwivedi M
Gene; 2021 Feb; 768():145295. PubMed ID: 33181260
[TBL] [Abstract][Full Text] [Related]
19. CYP2A13 genetic polymorphism in French Caucasian, Gabonese and Tunisian populations.
Cauffiez C; Pottier N; Tournel G; Lo-Guidice JM; Allorge D; Chevalier D; Migot-Nabias F; Kenani A; Broly F
Xenobiotica; 2005 Jul; 35(7):661-9. PubMed ID: 16316926
[TBL] [Abstract][Full Text] [Related]
20. Suppression of pulmonary CYP2A13 expression by carcinogen-induced lung tumorigenesis in a CYP2A13-humanized mouse model.
Liu Z; Megaraj V; Li L; Sell S; Hu J; Ding X
Drug Metab Dispos; 2015 May; 43(5):698-702. PubMed ID: 25710941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
